ClinicalTrials.gg
Enrolling by invitationNCT07688421Updated Jul 17, 2026

Short Implants Produced by Additive Manufacturing in the Posterior Jaws: 3 Years of Follow-up

An observational study in Periodontal Diseases and Dental Implant Failed, sponsored by University of Guarulhos. Enrolling by invitation at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by University of Guarulhos · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Periodontal Diseases with a site in Brazil — 5 open to participants now, 7 under way, 1 of them phase 3. Periodontal Diseases · Brazil.

Started
2026
with 3 others
Observational
8 of 64
2 open now
Registered
61st of 64
by date
Lead sponsor
6 of 64
University of Guarulhos

Among the 64 studies in Periodontal Diseases with a site in Brazil, this one is one of 4 that started in 2026, is one of 8 observational ones, and was the 61st registered.

Periodontal Diseases

871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.

Browse Periodontal Diseases studies →

Open to participants now

5 of the 64 studies in Periodontal Diseases with a site in Brazil are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Periodontal Diseases with a site in Brazil, or all of them as a file.
02

Study summary

Implant-supported rehabilitation of regions with severe bone resorption is a challenge for implant dentists. Structures such as the maxillary sinus and the inferior alveolar canal often make it impossible to use implants of lengths considered standard in the literature. The use of short implants produced by additive manufacturing (AM) provides a new surface, promoting osseointegration and reducing problems such as peri-implantitis. However, longitudinal evaluations of implants produced by AM are still scarce in the literature. A total of 100 subjects rehabilitated with short implants produced by MA, with diameters between 4.0 to 6.0 mm and 5 to 7 mm in length, will be evaluated. Peri-implant bone remodeling, as well as clinical parameters, will be evaluated by implant and throughout the evaluation time. Periapical radiographs will be obtained and scanned, analyzed by software, and compared to baseline data. The data obtained will be analyzed, allowing longitudinal evaluations and the success rate of implant restorations supported by short implants.

03

Conditions studied

  • Periodontal Diseases
  • Dental Implant Failed

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Individuals (> 21 years old), of both sexes, specifically rehabilitated with Morse connection implants (Plenum Bioengenharia, Jundiai, SP, Brazil) in the posterior region of the jaws for implant-supported restorations, will be included in this study. Subjects will need to have at least baseline radiographic controls (immediately after implant placement) and radiographic controls at 12 and 36 months after implant placement. Individuals will be included in the population sample based on the following criteria: location, region of implant installation, implant diameter, and adaptation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals (> 21 years old) with Morse connection implants in the posterior region of the jaws for implant-supported restorations; baseline radiographic controls (immediately after implant placement) and radiographic controls at 12 and 36 months after implant placement.

Exclusion criteria

Exclusion Criteria:

  • Immediate implants will be excluded; individuals with clinical records who, throughout the study, do not have radiographs for evaluation and/or radiographs of poor quality that make radiographic measurements impossible; medical records with insufficient data, filled out inappropriately, or that indicate doubt about the details of the procedure performed.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • Otherdiagonstic

    The aim of the study will be to evaluate the bone loss and peri-implant complications of short implants produced by additive manufacturing

06

What researchers measure

Primary outcomes

  1. The primary outcome variable of the study will be variation in bone remodeling between the initial and final values (measured in mm)

    Bone loss measured from the abutment-implant junction to the first visible bone to implant contact visible in a X-ray

    Time frame: 36 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026.

Of 79 non-industry observational studies under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 0 months is below that.

Counting every sponsor, half of 83 studies reached it within 13 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2026
First posted
Jul 7, 2026
StartEst.
Jun 28, 2026
Primary completionActual
Jun 28, 2026
CompletionEst.
Feb 28, 2027
Last update
Jul 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07688421
Lead sponsor
University of Guarulhos
Responsible party
Jamil awad shibli (professor, University of Guarulhos) — Principal investigator
First posted
Jul 7, 2026
Start date
Jun 28, 2026 (estimated)
Primary completion
Jun 28, 2026
Completion
Feb 28, 2027 (estimated)
Last update
Jul 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion